Modulation by progestogens of the effects of oestrogen on hepatic endocrine function in postmenopausal women.
D000704:Analysis of Variance; D002352:Carrier Proteins / Q000097:blood; D017373:Cyproterone Acetate / Q000627:therapeutic use; D004394:Dydrogesterone / Q000627:therapeutic use; D004958:Estradiol / Q000627:therapeutic use*; D015914:Estrogen Replacement Therapy; D004966:Estrogens, Conjugated (USP) / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D008055:Lipids / Q000097:blood; D008099:Liver / Q000187:drug effects* / Q000378:metabolism; D017258:Medroxyprogesterone Acetate / Q000627:therapeutic use; D008875:Middle Aged; D009640:Norethindrone / Q000627:therapeutic use; D017698:Postmenopause / Q000378:metabolism*; D011372:Progestins / Q000627:therapeutic use*; D012738:Sex Hormone-Binding Globulin / Q000032:analysis
D002352:Carrier Proteins; D004966:Estrogens, Conjugated (USP); D008055:Lipids; D011372:Progestins; D012738:Sex Hormone-Binding Globulin; D017373:Cyproterone Acetate; D004958:Estradiol; D007334:Insulin-Like Growth Factor I; D004394:Dydrogesterone; D017258:Medroxyprogesterone Acetate; D009640:Norethindrone; C051815:somatotropin-binding protein